ARTICLE | Company News
EKR, ProStrakan sales and marketing update
March 23, 2009 7:00 AM UTC
Under an exclusive, three-year, renewable deal, the partners will co-promote EKR's Gelclair povidone in the U.S. to treat pain associated with oral mucositis. EKR has North American rights to the bio...